Comprehensive profiles and diagnostic value of menopausal-specific gut microbiota in premenopausal breast cancer

다국어 초록 (Multilingual Abstract)

In Western countries, breast cancer tends to occur in older postmenopausal women. However, in Asian countries, the proportion of younger premenopausal breast cancer patients is increasing. Increasing evidence suggests that the gut microbiota plays a critical role in breast cancer. However, studies on the gut microbiota in the context of breast cancer have mainly focused on postmenopausal breast cancer. Little is known about the gut microbiota in the context of premenopausal breast cancer. This study aimed to comprehensively explore the gut microbial profiles, diagnostic value, and functional pathways in premenopausal breast cancer patients. Here, we analyzed 267 breast cancer patients with different menopausal statuses and age-matched female controls. The α-diversity was significantly reduced in premenopausal breast cancer patients, and the β-diversity differed significantly between breast cancer patients and controls. By performing multiple analyses and classification, 14 microbial markers were identified in the different menopausal statuses of breast cancer. Bacteroides fragilis was specifically found in young women of premenopausal statuses and Klebsiella pneumoniae in older women of postmenopausal statuses. In addition, menopausal-specific microbial markers could exhibit excellent discriminatory ability in distinguishing breast cancer patients from controls. Finally, the functional pathways differed between breast cancer patients and controls. Our findings provide the first evidence that the gut microbiota in premenopausal breast cancer patients differs from that in postmenopausal breast cancer patients and shed light on menopausal-specific microbial markers for diagnosis and investigation, ultimately providing a noninvasive approach for breast cancer detection and a novel strategy for preventing premenopausal breast cancer.

참고문헌 (Reference)

• 1 Lee, M. S., "Vitamin D decreases risk of breast cancer in premenopausal women of normal weight in subtropical taiwan" 21 : 87-94, 2011
• 2 Cheng, S. H., "Unique features of breast cancer in Taiwan" 63 : 213-223, 2000
• 3 Huang, C. S., "Unique features of breast cancer in Asian women–breast cancer in Taiwan as an example" 118 : 300-303, 2010
• 4 Biagi, E., "Through ageing, and beyond : gut microbiota and inflammatory status in seniors and centenarians" 5 : e10667-, 2010
• 5 Mager, D. L., "The salivary microbiota as a diagnostic indicator of oral cancer : a descriptive, non-randomized study of cancer-free and oral squamous cell carcinoma subjects" 3 : 27-, 2005
• 6 Cheng, W. T., "The mechanism of Bacteroides fragilis toxin contributes to colon cancer formation" 27 : 9-21, 2020
• 7 Zheng, Y., "Specific gut microbiome signature predicts the early-stage lung cancer" 11 : 1030-1042, 2020
• 8 Henke, M. T., "Ruminococcus gnavus, a member of the human gut microbiome associated with Crohn’s disease, produces an inflammatory polysaccharide" 116 : 12672-12677, 2019
• 9 Marchesi, J. R., "Rapid and noninvasive metabonomic characterization of inflammatory bowel disease" 6 : 546-551, 2007
• 10 Shin, N. R., "Proteobacteria : microbial signature of dysbiosis in gut microbiota" 33 : 496-503, 2015
• 11 Toi, M., "Probiotic beverage with soy isoflavone consumption for breast cancer prevention : a case-control study" 9 : 194-200, 2013
• 12 Walther-Antonio, M. R., "Potential contribution of the uterine microbiome in the development of endometrial cancer" 8 : 122-, 2016
• 13 Cani, P. D., "Next-generation beneficial microbes : the case of Akkermansia muciniphila" 8 : 1765-, 2017
• 14 Lin, P. H., "Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer" 7 : 8310-8320, 2016
• 15 Lin, C. H., "Molecular subtypes of breast cancer emerging in young women in Taiwan : evidence for more than just westernization as a reason for the disease in Asia" 18 : 1807-1814, 2009
• 16 Miko, E., "Microbiome-microbial metabolome-cancer cell interactions in breast cancer-familiar, but unexplored" 8 : 293-, 2019
• 17 Plottel, C. S., "Microbiome and malignancy" 10 : 324-335, 2011
• 18 Strakova, N., "Klebsiella pneumoniae producing bacterial toxin colibactin as a risk of colorectal cancer development—a systematic review" 197 : 126-135, 2021
• 19 Wang, L., "Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder" 4 : 42-, 2013
• 20 Blandino, G., "Impact of gut microbiota on diabetes mellitus" 42 : 303-315, 2016
• 21 Hwang, J., "Impact of air pollution on breast cancer incidence and mortality : a nationwide analysis in South Korea" 10 : 5392-, 2020
• 22 Mayneris-Perxachs, J., "Gut microbiota steroid sexual dimorphism and its impact on gonadal steroids : influences of obesity and menopausal status" 8 : 136-, 2020
• 23 Sampson, T. R., "Gut microbiota regulate motor deficits and neuroinflammation in a model of Parkinson’s disease" 167 : 1469-1480, 2016
• 24 Mosca, A., "Gut microbiota diversity and human diseases:should we reintroduce key predators in our ecosystem?" 7 : 455-, 2016
• 25 Festi, D., "Gut microbiota and metabolic syndrome" 20 : 16079-16094, 2014
• 26 O’Toole, P. W., "Gut microbiota : changes throughout the lifespan from infancy to elderly" 20 : 281-291, 2010
• 27 Feng, Q., "Gut microbiome development along the colorectal adenomacarcinoma sequence" 6 : 6528-, 2015
• 28 Ren, Z., "Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma" 68 : 1014-1023, 2019
• 29 Karlsson, F. H., "Gut metagenome in European women with normal, impaired and diabetic glucose control" 498 : 99-103, 2013
• 30 Fang Wang, "Gut Microbiota Community and Its Assembly Associated with Age and Diet in Chinese Centenarians" 한국미생물·생명공학회 25 (25): 1195-1204, 2015
• 31 Arboleya, S., "Gut Bifidobacteria populations in human health and aging" 7 : 1204-, 2016
• 32 de Martel, C., "Global burden of cancers attributable to infections in 2008 : a review and synthetic analysis" 13 : 607-615, 2012
• 33 Sung, H., "Global Cancer Statistics 2020 : GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries" 71 : 209-249, 2021
• 34 Rigiracciolo, D. C., "GPER is involved in the stimulatory effects of aldosterone in breast cancer cells and breast tumor-derived endothelial cells" 7 : 94-111, 2016
• 35 Farvid, M. S., "Fiber consumption and breast cancer incidence : A systematic review and meta-analysis of prospective studies" 126 : 3061-3075, 2020
• 36 Flores, R., "Fecal microbial determinants of fecal and systemic estrogens and estrogen metabolites : a cross-sectional study" 10 : 253-, 2012
• 37 Fruge, A. D., "Fecal Akkermansia muciniphila is associated with body composition and microbiota diversity in overweight and obese women with breast cancer participating in a presurgical weight loss trial" 120 : 650-659, 2020
• 38 Iebba, V., "Eubiosis and dysbiosis : the two sides of the microbiota" 39 : 1-12, 2016
• 39 Chen, K. L., "Estrogen and microbiota crosstalk: should we pay attention?" 27 : 752-755, 2016
• 40 Zhang, J., "Dysbiosis of the gut microbiome is associated with thyroid cancer and thyroid nodules and correlated with clinical index of thyroid function" 64 : 564-574, 2019
• 41 Heikkinen, S., "Does hair dye use increase the risk of breast cancer? a population-based case-control study of finnish women" 10 : e0135190-, 2015
• 42 Chang, S., "DDT exposure in early childhood and female breast cancer : evidence from an ecological study in Taiwan" 121 : 1106-1112, 2018
• 43 Petrakis, N. L., "Cytological abnormalities in nipple aspirates of breast fluid from women with severe constipation" 2 : 1203-1204, 1981
• 44 Lin, C. H., "Contrasting epidemiology and clinicopathology of female breast cancer in Asians vs the US population" 111 : 1298-1306, 2019
• 45 Zhao, H., "Compositional and functional features of the female premenopausal and postmenopausal gut microbiota" 593 : 2655-2664, 2019
• 46 Sun, M., "Combined signature of the fecal microbiome and plasma metabolome in patients with ulcerative colitis" 25 : 3303-3315, 2019
• 47 Li, N., "Characterization of the fecal microbiota in gastrointestinal cancer patients and healthy controls"
• 48 de Vocht, F., "Cancer mortality and occupational exposure to aromatic amines and inhalable aerosols in rubber tire manufacturing in Poland" 33 : 94-102, 2009
• 49 Garrett, W. S., "Cancer and the microbiota" 348 : 80-86, 2015
• 50 Narod, S. A., "Breast cancer in young women" 9 : 460-470, 2012
• 51 Zhu, J., "Breast cancer in postmenopausal women is associated with an altered gut metagenome" 6 : 136-, 2018
• 52 Laborda-Illanes, A., "Breast and gut microbiota action mechanisms in breast cancer pathogenesis and treatment" 12 : 2465-, 2020
• 53 Wei, H., "Antitumor mechanisms of bifidobacteria" 16 : 3-8, 2018
• 54 Malik, S. S., "Anticarcinogenecity of microbiota and probiotics in breast cancer" 21 : 655-666, 2018
• 55 Wang, Z., "Altered diversity and composition of the gut microbiome in patients with cervical cancer" 9 : 40-, 2019
• 56 Panda, M., "Alterations of salivary microbial community associated with oropharyngeal and hypopharyngeal squamous cell carcinoma patients" 202 : 785-805, 2020
• 57 Ma, J., "Alter between gut bacteria and blood metabolites and the anti-tumor effects of Faecalibacterium prausnitzii in breast cancer" 20 : 82-, 2020
• 58 Iwase, M., "Alcohol consumption and breast cancer risk in Japan : a pooled analysis of eight population-based cohort studies" 148 : 2736-2747, 2021
• 59 Shih, C. T., "Akkermansia muciniphila is negatively correlated with hemoglobin A1c in refractory diabetes" 8 : 1360-, 2020
• 60 Parida, S., "A procarcinogenic colon microbe promotes breast tumorigenesis and metastatic progression and concomitantly activates notch and beta-catenin axes" 11 : 1138-1157, 2021